Additionally, the association between elevated RRM2 serum levels and advanced tumor stage in liver cancer suggests that it could serve as a promising indicator of sensitivity to ferroptosis and as a factor that can be targeted for cancer therapy. The gene discussed is RRM2; the disease is liver cancer.